Author:
Varga John,Hinchcliff Monique
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. LeRoy, E. C. et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 15, 202–205 (1988).
2. Gliddon, A. E. et al. Antinuclear antibodies and clinical associations in a British cohort with limited cutaneous systemic sclerosis. J. Rheumatol. 38, 702–705 (2011).
3. Meyer, O. C., Fertig, N., Lucas, M., Somogyi, N., & Medsger, T. A. Jr. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J. Rheumatol. 34, 104–109 (2007).
4. Moinzadeh, P. et al. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis. Ann. Rheum. Dis.
http://dx.doi.org/10.1136/annrheumdis-2013-204487
.
5. Pakozdi, A. et al. Clinical and serological hallmarks of systemic sclerosis overlap syndromes. J. Rheumatol. 38, 2406–2409 (2011).
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献